Dr. Kamil J. Detyniecki, MD

Dr. Detyniecki practices at UMiami Medicine - Neurology in Miami, Florida.

Dr. Detyniecki's NPI, 1295998441, was assigned on July 8, 2008. Dr. Detyniecki graduated from Medical University of Warsaw in 2001. Dr. Detyniecki holds Florida license ME137735.

Dr. Detyniecki's primary practice is UMiami Medicine - Neurology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-4951.

Dr. Detyniecki's primary practice is UMiami Medicine - Neurology in Miami, Florida. Dr. Detyniecki is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Detyniecki to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Detyniecki practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Detyniecki's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Detyniecki is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Detyniecki's licenses on file in 3 states: Florida, Connecticut and Pennsylvania.

Dmand AI lists epilepsy and seizures among the conditions Dr. Detyniecki treats.

CMS data shows 132 Medicare services from Dr. Detyniecki across 5 procedure codes in 2024, for 135 Medicare patients. Medicare paid $11,801 for them.

CMS counts 135 Medicare patients who saw Dr. Detyniecki in 2024. The largest group is under 65, with 53 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 61% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Detyniecki's median patient age at 51, with 46% women.

In 2024, Dr. Detyniecki wrote 1,549 Medicare Part D claims for 150 patients. 61% of them were for generic drugs. CMS names the drug for 1,383 of them, across 30 drugs with 11 or more claims each, at $1,214,015 in total drug cost. In 2023, CMS named 1,713 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Detyniecki for performance year 2024, reported as part of a group. Dr. Detyniecki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Detyniecki as offering telehealth.

Dmand AI links 49 papers to Dr. Detyniecki, published from 2011 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Anticonvulsants, Seizures and Epilepsy. Dr. Detyniecki has published most often in Epilepsia. Dr. Detyniecki's most frequent co-authors are Hyunmi Choi, MD, Hal Blumenfeld, MD and Baibing Chen, MD.

Dmand AI links Dr. Detyniecki to 9 clinical trials, 3 of them phase 2 studies. Conditions studied include Epilepsy, Brain Diseases and Seizures. UCB Biopharma S.P.R.L. sponsors the most, 3.

CMS Open Payments shows 229 general payments to Dr. Detyniecki from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. UCB, Inc. paid the most, $54,598. It also lists 4 research payments totaling $4,760 from 2019 to 2020.

Dmand AI lists 1 award for Dr. Detyniecki, most recently CMS Stage 1 EHR in 2013.

Dr. Detyniecki graduated from Medical University of Warsaw in 2001. Dr. Detyniecki is a member of AAN and AES.

Dr. Detyniecki is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.